Page 47 - Access Pool News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AstraZeneca has claimed it does not have enough engineers to help share its vital Covid vaccine technology with other global manufacturers, as other pharmaceutical giants face growing pressure to relinquish their control over the production of the life-saving jabs. Amid a global shortage of supplies, health campaigners have called on the likes of AstraZeneca, Pfizer, Moderna and others to waive their intellectual property (IP) rights and...

Commentary: Glaring vaccine gaps across the world are too big to ignore Toggle share menu Advertisement Commentary: Glaring vaccine gaps across the world are too big to ignore Many hoped the pandemic would end proprietary science and patent-based market monopolies. That hope has since faded, says Kaushik Basu. FILE PHOTO: A health worker prepares a dose of the Sputnik V (Gam-COVID-Vac) vaccine against the coronavirus disease (COVID-19) at the Tecnopolis Park, in Buenos Aires, Argentina April 15, 2021. REUTERS/Agustin Marcarian 05 May 2021 06:10A...

May 3, 2021 ITHACA, New York – As the second wave of the COVID-19 pandemic outstrips the severity of the first, a clear global bifurcation is emerging. The pandemic is abating, gradually and unevenly, across richer countries, but flaring up in several developing and emerging economies, most notably India, but also to varying degrees in countries such as Bangladesh, Pakistan, Turkey, the Philippines, Ethiopia, and Kenya. There are many reasons for this divide, but uneven access to health care — particularly the glaring inequity in access to COVID-19 vaccines — is impossible to i...

Inequity in access to Covid-19 vaccines abets second wave Kaushik Basu More than one billion vaccine doses have now been administered worldwide, but vast disparities remain. As the second wave of the Covid-19 pandemic outstrips the severity of the first, a clear global bifurcation is emerging. The pandemic is abating, gradually and unevenly, across richer countries, but flaring up in several developing and emerging economies, most notably India, but also to varying degrees in countries such as Bangladesh, Pakistan, Turkey, the Philippines, Ethiopia, and Kenya. There are many reasons for this ...

Vaccine companies and the U.S. government snubbed WHO initiative to scale up global manufacturing Emily Baumgaertner © (Rafiq Maqbool / Associated Press) The Serum Institute in India has been responsible for manufacturing vaccines for much of the world. (Rafiq Maqbool / Associated Press) COVID-19 vaccines were still in the early stages of development last spring, but Costa Rican President Carlos Alvarado Quesada was thinking ahead. Even if those efforts were successful, he figured, wealthy nations alone wouldn't be able to make enough vaccine to quickly inoculate billions o...